within Pharmacolibrary.Drugs.ATC.V;

model V04CE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.38333333333333336,
    adminDuration  = 600,
    adminMass      = 0.002,
    adminCount     = 1,
    Vd             = 0.00062,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Methacetin (13C) is a stable isotope-labeled derivative of methacetin used as a diagnostic agent for assessing liver function, particularly via the 13C-Methacetin Breath Test (MBT). It is not an approved therapeutic drug but is used in liver diagnostics to evaluate hepatic microsomal function and metabolic capacity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult volunteers (mean age ~30-35 years) following intravenous administration reported in diagnostic liver function testing studies.</p><h4>References</h4><ol><li><p>Lock, JF, et al., &amp; Stockmann, M (2013). Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. <i>Annals of hepatology</i> 12(4) 556â€“562. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23813133/&quot;>https://pubmed.ncbi.nlm.nih.gov/23813133</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CE03;
